Key result
Moderate cutaneous psoriasis in young patients without cardiovascular comorbidities was associated with an imbalance toward sympathetic autonomic cardiac modulation.
Why the study?
Does moderate cutaneous psoriasis increase cardiovascular risk as detected by heart rate variability analysis in young patients without CV comorbidities?
Observational
Does moderate cutaneous psoriasis increase cardiovascular risk as detected by heart rate variability analysis in young patients without CV comorbidities?
Young patients with moderate cutaneous psoriasis exhibit an imbalance toward sympathetic autonomic cardiac modulation, suggesting increased cardiovascular risk even without established CV comorbidities.
Patients affected by severe psoriasis have an increased prevalence of cardiovascular () diseases as documented by several studies. Heart rate variability (HRV) is a noninvasive method to evaluate the autonomic control of the sinus node. In this study, HRV analysis has been used to evaluate whether young patients with moderate cutaneous psoriasis have increased cardiovascular (CV) risk, in absence of CV comorbidities. Our data indicate an imbalance toward the sympathetic arm of the autonomic cardiac modulation. As the increase in sympathetic activity may be associated with a higher CV risk, moderate psoriasis could be considered to be an independent CV risk factor.
No takes yet. Share an insight, caveat, or question.
Proietti et al. (2014) conducted an observational in Moderate cutaneous psoriasis. Moderate cutaneous psoriasis was evaluated on Autonomic cardiac modulation assessed by HRV analysis. Moderate cutaneous psoriasis in young patients without cardiovascular comorbidities was associated with an imbalance toward sympathetic autonomic cardiac modulation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: